Agenda BBS Spring 2010 Conference PDF
Benda Norbert, The use of adaptive designs in dose finding studies
Brannath Werner, Challenges in the application of adaptive phase II/III designs in oncology
Fleischer Frank, Statistical modeling in the context of progression-free survival
Friede Tim, Blinded sample size reestimation with count data
Glimm Ekkehard, Some lessons learned from designing and adaptive clinical trial with time-to-event as the primary endpoint
Guthjahr Georg, Multiple Type I error control in response adaptive Phase II/III designs with treatment selection
Wang Sue-Jane, U.S. FDA Draft Guidance on Adaptive Design Clinical Trials – Statistical Considerations and Issues
FDA, Guidance for Industry: Adaptive Design Clinical Trials for Drugs and Biologics
Sorry, the comment form is closed at this time.